“Assigned an 'Outperform' rating to MCX with a target price of ₹3,830, indicating a 15% upside. This bullish view is driven by strong momentum in commodity derivatives, which are still in an early stage of participation, and expected continued growth in traded contracts. Regulatory developments like the FPI consultation paper are also seen as supportive for the segment.”